Skip to main content

Incyte JAKAVI revenue

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

JAKAVI revenue at Incyte came to $132.5M for the quarter to 30 Sep 2026, up 5.4% from a year earlier.

As Incyte reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$103.9MDec 2023$89.6MMar 2024$99.3MJun 2024$115.7MSep 2024$114.2MDec 2024$92.1MMar 2025$109.7MJun 2025$125.6MSep 2025$130.2MDec 2025$105.6MMar 2026$124.2MJun 2026$132.5MSep 2026
Incyte JAKAVI revenue, every reported period
Period endingJAKAVI revenueChange on a yearFiled
30 Sep 2026$132.5Mup 5.4%29 Oct 2026
30 Jun 2026$124.2Mup 13.2%28 Jul 2026
31 Mar 2026$105.6Mup 14.6%28 Apr 2026
31 Dec 2025$130.2Mup 14.0%10 Feb 2026
30 Sep 2025$125.6Mup 8.6%28 Oct 2025
30 Jun 2025$109.7Mup 10.5%29 Jul 2025
31 Mar 2025$92.1Mup 2.8%29 Apr 2025
31 Dec 2024$114.2Mup 9.9%10 Feb 2025
30 Sep 2024$115.7Mup 19.9%29 Oct 2024
30 Jun 2024$99.3Mup 9.8%30 Jul 2024
31 Mar 2024$89.6Mup 16.8%30 Apr 2024
31 Dec 2023$103.9Mup 13.9%13 Feb 2024
30 Sep 2023$96.6Mup 12.5%31 Oct 2023
30 Jun 2023$90.4Mup 8.0%1 Aug 2023
31 Mar 2023$76.7Mup 8.2%2 May 2023
31 Dec 2022$91.2Mdown 4.7%7 Feb 2023
30 Sep 2022$85.8Mdown 9.3%1 Nov 2022
30 Jun 2022$83.7Mup 2.0%2 Aug 2022
31 Mar 2022$70.9Mup 8.0%3 May 2022
31 Dec 2021$95.7Mup 9.9%8 Feb 2022
30 Sep 2021$94.7Mup 38.6%2 Nov 2021
30 Jun 2021$82.0Mup 23.9%3 Aug 2021
31 Mar 2021$65.6Mup 16.5%4 May 2021
31 Dec 2020$87.0Mup 33.9%9 Feb 2021
30 Sep 2020$68.3Mup 16.9%5 Nov 2020
30 Jun 2020$66.2Mup 16.4%4 Aug 2020
31 Mar 2020$56.3Mup 23.6%5 May 2020
31 Dec 2019$65.0Mup 17.5%13 Feb 2020
30 Sep 2019$58.4Mup 14.8%29 Oct 2019
30 Jun 2019$56.9Mup 20.8%30 Jul 2019
31 Mar 2019$45.6Mup 10.2%30 Apr 2019
31 Dec 2018$55.3M—14 Feb 2019
30 Sep 2018$50.9M—30 Oct 2018
30 Jun 2018$47.1M—31 Jul 2018
31 Mar 2018$41.3M—1 May 2018

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Incyte: Customer A (change on a year) · Customer B (change on a year) · Customer C (change on a year) · JAKAFI revenue · OPZELURA revenue · Product royalty revenues · NIKTIMVO revenue · ZYNYZ revenue · MINJUVI/MONJUVI revenue · Milestone and contract revenues · OLUMIANT revenue · ICLUSIG revenue · PEMAZYRE revenue · TABRECTA revenue · United States revenue · Europe revenue · financial statements

Every KPI and segment of INCY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.